Frenadol, Gelocatil and other flu drugs reviewed by Europe for brain risk

The pseudoefedrina It is one of the drugs that sells the most in winter because it is used to treat nasal congestion Usually caused by colds or flu. It is also used in case of allergy to relieve rhinitis, so its use goes beyond the winter months in which there are more colds.

Now the drug is in the crosshairs of the European Medicines Agency (EMA) for its possible risk to the brain. In a statement issued by the agency, it reports that “the safety committee of the EMA has initiated a review of medicines containing pseudoefedrina after concerns about the risk of reversible posterior encephalopathy syndrome (CHAIR) and the reversible cerebral vasoconstriction syndrome (RCVS), diseases that affect the blood vessels of the brain”.

How does pseudoephedrine work?

The EMA explains that pseudoephedrine works by stimulating the Nerve endings to release the chemical norepinephrine, which causes blood vessels to narrow. In this way, the amount of fluid released by the vessels is reduced, thereby decreasing the inflammation and the production of mucus in the nose.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.